Background illustration for clinical trials search

Glomerulonephritis Clinical Trials

Browse 72 glomerulonephritis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Active & Responsive

Belimumab With Rituximab for Primary Membranous Nephropathy

for
Membranous Nephropathy, Nephrotic Syndrome
Location: New York NY, Philadelphia PA, Baltimore MD, Bethesda MD,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70+

Code: NCT03949855

Phase2, Recruiting
Active & Responsive

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

for
Lupus Nephritis
Location: Columbus OH, Lawrenceville GA, Atlanta GA,
Sponsor: NephroNet, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07225387

Recruiting
Active & Responsive

Lupus Landmark Study: A Prospective Registry and Biorepository

for
Systemic Lupus Erythematosus (SLE), Lupus Nephritis,
Location: Boston MA, Worcester MA, Quebec, Manhasset NY,
Sponsor: Lupus Research Alliance

Sex: All

Age: 18 - 70+

Code: NCT05934149

Recruiting
Active & ResponsiveNew

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

for
Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)
Location: New Hyde Park NY
Sponsor: iCell Gene Therapeutics

Sex: All

Age: 16 - 70

Code: NCT07328581

Phase2, Recruiting
Active & Responsive

Nephrotic Syndrome Study Network

for
Minimal Change Disease (MCD), Membranous Nephropathy,
Location: New Hyde Park NY, The Bronx NY, New York NY,
Sponsor: University of Michigan

Sex: All

Age: 0 - 70+

Code: NCT01209000

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

ASF Alport Patient Registry

for
Alport Syndrome, Thin Basement Membrane Disease,
Location: Scottsdale AZ
Sponsor: Alport Syndrome Foundation

Sex: All

Age: 0+

Code: NCT06526741

Recruiting
Active & Responsive

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

for
Focal Segmental Glomerulosclerosis, Minimal Change Disease,
Location: Ann Arbor MI
Sponsor: University of Michigan

Sex: All

Age: 0+

Code: NCT05650619

Recruiting
Active & Responsive

NEPTUNE Match Study

for
Nephrotic Syndrome in Children,
Location: New Hyde Park NY, New York NY, Philadelphia PA,
Sponsor: University of Michigan

Sex: All

Age: 1 - 70+

Code: NCT04571658

Recruiting
Active & Responsive

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

for
Lupus Nephritis, Systemic Lupus Erythematosus,
Location: Fayetteville NC, Miami FL, Cooper City FL,
Sponsor: Fate Therapeutics

Sex: All

Age: 12 - 70

Code: NCT07570862

Phase2, Recruiting
Active & Responsive

Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)

for
IgA Nephropathy (IgAN)
Location: Jacksonville FL, Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06676579

Phase2, Recruiting

Obinutuzumab in Treatment of Fibrillary Glomerulonephritis

for
Fibrillary Glomerulonephritis
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06295770

Phase2, Recruiting

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

for
Kidney Diseases, Kidney Failure, Chronic, Diabetic Nephropathy,
Location: New York NY
Sponsor: The Rogosin Institute

Sex: All

Age: 18+

Code: NCT01802034

Recruiting

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

for
Glomerulonephritis, IGA, Immunoglobulin A Nephropathy
Location: Orlando FL, Cleveland OH, Columbus OH, Lawrenceville GA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06797518

Phase2, Recruiting

Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

for
Nephrotic Syndrome, Proteinuria, Autoimmune Disease,
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 18 - 70+

Code: NCT00977977

Phase2, Recruiting

Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

for
C3 Glomerulopathy,
Location: New York NY, Lawrenceville GA, Iowa City IA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT03955445

Phase3, Recruiting
New

A Sequential Phase 2/3 Study of APL2 in Patients With Focal Segmental Glomerulosclerosis

for
FSGS
Location: New York NY, Chicago IL
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07213960

Phase2, Phase3, Recruiting

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

for
Fluid Overload, Glomerulosclerosis, Focal Segmental, Edema,
Location: Ann Arbor MI
Sponsor: University of Michigan

Sex: All

Age: 2+

Code: NCT05505500

Recruiting

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

for
Lupus Nephritis
Location: New York NY, Hackensack NJ, Chapel Hill NC,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 8 - 20

Code: NCT05538208

Phase2, Recruiting

Research Accelerated by You Lupus Registry

for
Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN),
Location: Washington D.C. DC
Sponsor: Lupus Foundation of America

Sex: All

Age: 0+

Code: NCT06927219

Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

for
SLE (Systemic Lupus), Lupus Erythematosus, Systemic,
Location: Boston MA, Chapel Hill NC, Chicago IL, New Orleans LA,
Sponsor: CRISPR Therapeutics

Sex: All

Age: 18 - 70

Code: NCT06925542

Phase1, Recruiting